finance.yahoo.com ·
opch q1 deep dive revenue 004455254
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedOption Care Health, a home infusion and specialty pharmacy provider, reported a revenue miss and lowered guidance due to operational issues in chronic therapy and insurance-driven patient census decline. The impact is company-specific, affecting its revenue and margin outlook. No broader sector or commodity mechanism is evident.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- OPCH Q1 CY2026 revenue $1.35B, +1.3% YoY, missed $1.40B estimate.
- Full-year revenue guidance lowered to $5.73B from $5.9B.
- Adjusted EPS guidance maintained at $1.87; non-GAAP EPS $0.40 beat by 8.1%.
- Operational challenges in chronic therapy segment and patient census decline due to insurance changes.
- Market cap $3.19B.
Home infusion services face downward pressure in sentiment within 48h; magnitude 1-2%.
Sign in to see all sector verdicts, full thesis and counter-argument debate.